Breast Cancer Equipment & Supplies
298 equipment items found
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
The thickness of Mimetix scaffold allows for having a 3D environment while maintaining a certain translucence, thus allowing for easy and robust imaging. This study has investigated the localisation depth of MCF7 breast cancer cells in the Mimetix scaffold after 4 days of culture (nuclei stained with TO-PRO-3, blue). The video below shows a Z-stack (slices ...
Manufactured by:OncoQR ML GmbH based inVienna, AUSTRIA
Lead candidate OQR200 is a new candidate against HER2/neu, the by far best characterized and clinically validated target to treat breast cancer indications. A reversible induction of HER2/neu specific antibodies has been demonstrated. In vitro, the immune response induced by OQR200 has been shown to have superior efficacy in a direct side by side comparison with ...
Manufactured by:Sysmex Partec GmbH based inGoerlitz, GERMANY
Precise lymph node analysis providing accurate staging, Reliable diagnostic information for therapy decision, High flexibility in multi-cancer application (CE-marked for breast, colon and gastric cancer). Axillary management and the relevance of sentinel lymph node biopsy (SLNB) have undergone major changes in the last years. Clinical trials, ...
by:Alfa Cytology based inU.S. VIRGIN ISLANDS
Cow Breast Cancer Anti-Estrogen Protein 3 (BCAR3) ELISA Kit is designed for the in vitro quantitative analysis of Cow Breast Cancer Anti-Estrogen Protein 3 in tissue homogenates, cell lysates and other biological fluids. ...
Manufactured by:Menssana Research Inc. based inEdgewater, NEW JERSEY (USA)
It takes 300 screening mammograms to discover one woman with breast cancer. A breath test might improve this very low yield. Researchers have known for many years that women with breast cancer have abnormal volatile organic compounds (VOCs) in their breath. Clinical studies at Menssana Research have shown that these breath VOCs ...
Manufactured by:Cellanyx, LLC based inBeverly, MASSACHUSETTS (USA)
Risk stratification of early-stage breast cancer is an active area of research and several commercially available products that are based on genotypic classification. A vexing issue in breast cancer is carcinoma in situ – which has no metastatic potential. There are two sub types – Ductal Carcinoma in Situ (DCIS) and ...
Manufactured by:ScreenPoint Medical based inNijmegen, NETHERLANDS
The resulting product, Transpara, has featured in multiple peer-reviewed publications that show it enables significant clinical improvements to the timely diagnosis of breast cancer. “Transpara is now being used by radiologists in clinical practice, but this is only the beginning! We are constantly innovating and we will continue to help doctors to ...
Manufactured by:Micrima Limited based inBristol, UNITED KINGDOM
Micrima are aiming to open up breast screening to all women. With breast cancer being the most common cancer in women of all ages globally, we believe that all women should be able to have breast screening. The current option for screening is mammography, which has limitations in women with dense ...
Manufactured by:IceCure Medical Ltd based inCaesarea, ISRAEL
We are dedicated to providing reliable clinical support for the ProSense™ System, so that physicians and other stakeholders can adopt our technology with confidence as the gold standard in tumor therapy. ICE3 is the largest controlled multilocation clinical trial ever performed for liquid nitrogen (LN2) –based cryoablation of small, low-risk, early-stage malignant breast tumors ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
Multigene prognostic test predicts the probability of metastasis or recurrence, which helps patients make treatment decision. It improves quality of life for cancer patients as preventing them from unnecessary ...
Manufactured by:Prestige Ameritech based inNorth Richland Hillsq, TEXAS (USA)
Our Pink Ribbon Masks will let everyone know that you are part of the effort to raise breast cancer awareness this October. ...
Manufactured by:TriStar Technology Group LLC based inWashington, DISTRICT OF COLUMBIA (USA)
Molecular Data: Yes; Approx. # of Donors: 72; Follow Up Data: No; Cores per Donor: 2; Core Size: 1mm; Approx. # of Cores *: 144; TA number: TA3124; List of markers: CD3, CD4, CD8, CD20, CD68, CD163, FOXP3, PD1, PD-L1(22C3); Suitable for (IHC or RNA-ISH): IHC; Suitable for CODEX/GeoMx/CosMx: ...
Manufactured by:Novodiax, Inc. based inHayward, CALIFORNIA (USA)
Pan Cytokeratin (CK) AE1/AE3 cocktail is a polymerized horseradish peroxidase (pHRP)-labeled anti human Pan CK (Clone AE1/AE3) antibody intended for laboratory use to qualitatively identify by light microscopy the presence of cytokeratins which are expressed in tissues of epithelial origin, including squamous and glandular epithelial cells, in sections of formalin-fixed, paraffin-embedded (FFPE) ...
Manufactured by:Caprico Biotechnologies, Inc. (CBI) based inNorcross, GEORGIA (US) (USA)
Predictive or prognostic factor in metastatic breast ...
Manufactured by:Cerca Biotech based inBerlin, GERMANY
Upon binding of progesterone, the receptor is activated and modifies expression of several downstream genes. Estrogen and progesterone receptors are found in Breast Cancer cells that depend on estrogen and related hormones (such as progesterone) to grow. All patients with invasive Breast Cancer or a Breast ...
Manufactured by:SEQENS Group based inÉcully, FRANCE
Anastrozole is a competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of postmenopausal women with estrogen-responsive breast ...
Manufactured by:Shanghai Henlius Biotech, Inc based inShanghai, CHINA
(trastuzumab, Zercepac in the EU) was successfully launched in China and Europe, becoming the first Chinese mAb biosimilar entering both the EU and China market. It is indicated for the treatment of HER2 positive early breast cancer, metastatic breast cancer and metastatic gastric cancer, which corresponds to all ...
Manufactured by:The Menarini Group based inFlorence, ITALY
Elacestrant is a selective estrogen receptor degrader (SERD) evaluated for potential use as a once daily oral treatment in patients with estrogen receptor positive (ER+)/HER2- advanced or metastatic breast cancer. Studies completed to date, including the positive results from the EMERALD phase 3 trial, indicate that the compound has the potential for use as a ...
Manufactured by:ACROBiosystems based inNewark, DELAWARE (USA)
Trastuzumab, is a monoclonal antibody used to treat breast cancer. Specifically it is used for breast cancer that is HER2 receptor positive. Trastuzumab works by binding to the HER2 receptor and slowing down cell duplication. Trastuzumab is a recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with high ...
Manufactured by:Cerca Biotech based inBerlin, GERMANY
ERBB2 activation stimulates cell proliferation and inhibits programmed cell death. ERBB2 has an important role in Breast Cancer. About 20 % of all Breast Cancers show an overexpression of this receptor, which is associated with poor prognosis and clinical outcome. Patients with an ERBB2 overexpression can benefit from an ...